Remove Genetic Analysis Remove Genome Remove Life Science
article thumbnail

Genetic Analysis co-develops HumGut – the world’s first complete database of reference genomes from the human gut microbiome

Drug Discovery Today

(Oslo, August 5, 2021) Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced the first publication from the comprehensive HumGut microbiome database has appeared in the leading scientific journal Microbiome.

article thumbnail

International Women’s Day 2024: A Spotlight on 5 Women’s Health Webinars with Xtalks

XTalks

Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity This on-demand webinar introduces a cutting-edge single-cell multiomics method designed for garnering detailed genetic insights into breast cancer. Through this, researchers can pinpoint breast cancer cell types and their phenotypic states.

Genetics 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services

XTalks

Fortunately, technological advances — such as those pioneered by Menarini Silicon Biosystems — have allowed researchers and healthcare practitioners to decipher these issues, drilling down to single-cell genomic levels to uncover variations that may account for reduced drug efficacy or biochemical resistance.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

Additionally, CRISPR genome-wide screening holds great potential for identifying key disease-associated genes and uncovering novel therapeutic targets. Furthermore, CRISPR/Cas9 presents a promising avenue for overcoming genetic diseases in the near future. The global NGS market is projected to grow from $13.0 billion in 2022 to $27.0